CASETTI, ILARIA CAROLA
CASETTI, ILARIA CAROLA
DIPARTIMENTO DI MEDICINA MOLECOLARE
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis
2021-01-01 Trotti, C; Sant'Antonio, E; Vanni, D; Casetti, Ic; Borsani, O; Pietra, D; Ferretti, Vv; Astori, C; Arcaini, L; Rumi, E.
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
2022-01-01 Borsani, Oscar; Bastard, Paul; Rosain, Jérémie; Gervais, Adrian; Sant'Antonio, Emanuela; Vanni, Daniele; Casetti, Ilaria Carola; Pietra, Daniela; Trotti, Chiara; Catricalà, Silvia; Ferretti, Virginia Valeria; Malcovati, Luca; Arcaini, Luca; Casanova, Jean-Laurent; Borghesi, Alessandro; Rumi, Elisa
COVID-19 in Patients with Hematologic Diseases
2022-01-01 Casetti, Ic; Borsani, O; Rumi, E.
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
2016-01-01 Pietra, D.; Rumi, E.; Ferretti, V. V.; Di Buduo, C. A.; Milanesi, C.; Cavalloni, C.; Sant'Antonio, E.; Abbonante, V.; Moccia, F.; Casetti, I. C.; Bellini, M.; Renna, M. C.; Roncoroni, E.; Fugazza, E.; Astori, C.; Boveri, E.; Rosti, V.; Barosi, G.; Balduini, A.; Cazzola, M.
Genomic profiling and genotype-phenotype correlations in myeloproliferative neoplasms
2021-12-15 Casetti, ILARIA CAROLA
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms
2022-01-01 Vanni, Daniele; Borsani, Oscar; Nannya, Yasuhito; Sant'Antonio, Emanuela; Trotti, Chiara; Casetti, Ilaria Carola; Pietra, Daniela; Gallì, Anna; Zibellini, Silvia; Ferretti, Virginia Valeria; Malcovati, Luca; Ogawa, Seishi; Arcaini, Luca; Rumi, Elisa
Isolated congenital asplenia: An overlooked cause of thrombocytosis
2022-01-01 Borsani, O; Asano, T; Boisson, B; Fraticelli, S; Braschi-Amirfarzan, M; Pietra, D; Casetti, Ic; Vanni, D; Trotti, C; Borghesi, A; Casanova, Jl; Arcaini, L; Rumi, E.
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin
2014-01-01 Pietra, Daniela; Rumi, Elisa; Chiara, Milanesi; DI BUDUO, CHRISTIAN ANDREA; Bellini, Marta; Casetti, ILARIA CAROLA; Cavalloni, Chiara; Sant'Antonio, Emanuela; Abbonante, Vittorio; Renna, MARIA CONCETTA; Ferretti, VIRGINIA VALERIA; Boveri, Emanuela; Balduini, Alessandra; Pascutto, Cristiana; Cazzola, Mario
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis
In corso di stampa Mora, B.; Siracusa, C.; Rumi, E.; Maffioli, M.; Casetti, I. C.; Barraco, D.; Merli, M.; Rossi, M.; Ubezio, M.; Accetta, R.; Libera, L.; Pietra, D.; Trotti, C.; Uccella, S.; Pallotti, F.; Casalone, R.; Bertu, L.; Arcaini, L.; Della Porta, M. G.; Passamonti, F.
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients
2022-01-01 Mora, B; Guglielmelli, P; Kuykendall, A; Rumi, E; Maffioli, M; Palandri, F; De Stefano, V; Caramella, M; Salmoiraghi, S; Kiladjian, Jj; Gotlib, J; Iurlo, A; Cervantes, F; Ruggeri, M; Silver, Rt; Albano, F; Benevolo, G; Ross, Dm; Della Porta, Mg; Devos, T; Rotunno, G; Komrokji, Rs; Casetti, Ic; Merli, M; Brociner, M; Caramazza, D; Auteri, G; Barbui, T; Cattaneo, D; Bertù, L; Arcaini, L; Vannucchi, Am; Passamonti, F.
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
2023-01-01 Borsani, O; Ferretti, Vv; Casetti, Ic; Vanni, D; Trotti, C; Pietra, D; De Silvestri, A; Arcaini, L; Rumi, E.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
2023-01-01 Pecquet, C; Papadopoulos, N; Balligand, T; Chachoua, I; Tisserand, A; Vertenoeil, G; Nédélec, A; Vertommen, D; Roy, A; Marty, C; Nivarthi, H; Defour, Jp; El-Khoury, M; Hug, E; Majoros, A; Xu, E; Zagrijtschuk, O; Fertig, Te; Marta, Ds; Gisslinger, H; Gisslinger, B; Schalling, M; Casetti, I; Rumi, E; Pietra, D; Cavalloni, C; Arcaini, L; Cazzola, M; Komatsu, N; Kihara, Y; Sunami, Y; Edahiro, Y; Araki, M; Lesyk, R; Buxhofer-Ausch, V; Heibl, S; Pasquier, F; Havelange, V; Plo, I; Vainchenker, W; Kralovics, R; Constantinescu, Sn.
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
2022-01-01 Ibarra, J; Elbanna, Ya; Kurylowicz, K; Ciboddo, M; Greenbaum, Hs; Arellano, Ns; Rodriguez, D; Evers, M; Bock-Hughes, A; Liu, C; Smith, Q; Lutze, J; Baumeister, J; Kalmer, M; Olschok, K; Nicholson, B; Silva, D; Maxwell, L; Dowgielewicz, J; Rumi, E; Pietra, D; Casetti, Ic; Catricala, S; Koschmieder, S; Gurbuxani, S; Schneider, Rk; Oakes, Sa; Elf, Se.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis | 1-gen-2021 | Trotti, C; Sant'Antonio, E; Vanni, D; Casetti, Ic; Borsani, O; Pietra, D; Ferretti, Vv; Astori, C; Arcaini, L; Rumi, E. | |
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms | 1-gen-2022 | Borsani, Oscar; Bastard, Paul; Rosain, Jérémie; Gervais, Adrian; Sant'Antonio, Emanuela; Vanni, Daniele; Casetti, Ilaria Carola; Pietra, Daniela; Trotti, Chiara; Catricalà, Silvia; Ferretti, Virginia Valeria; Malcovati, Luca; Arcaini, Luca; Casanova, Jean-Laurent; Borghesi, Alessandro; Rumi, Elisa | |
COVID-19 in Patients with Hematologic Diseases | 1-gen-2022 | Casetti, Ic; Borsani, O; Rumi, E. | |
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms | 1-gen-2016 | Pietra, D.; Rumi, E.; Ferretti, V. V.; Di Buduo, C. A.; Milanesi, C.; Cavalloni, C.; Sant'Antonio, E.; Abbonante, V.; Moccia, F.; Casetti, I. C.; Bellini, M.; Renna, M. C.; Roncoroni, E.; Fugazza, E.; Astori, C.; Boveri, E.; Rosti, V.; Barosi, G.; Balduini, A.; Cazzola, M. | |
Genomic profiling and genotype-phenotype correlations in myeloproliferative neoplasms | 15-dic-2021 | Casetti, ILARIA CAROLA | |
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms | 1-gen-2022 | Vanni, Daniele; Borsani, Oscar; Nannya, Yasuhito; Sant'Antonio, Emanuela; Trotti, Chiara; Casetti, Ilaria Carola; Pietra, Daniela; Gallì, Anna; Zibellini, Silvia; Ferretti, Virginia Valeria; Malcovati, Luca; Ogawa, Seishi; Arcaini, Luca; Rumi, Elisa | |
Isolated congenital asplenia: An overlooked cause of thrombocytosis | 1-gen-2022 | Borsani, O; Asano, T; Boisson, B; Fraticelli, S; Braschi-Amirfarzan, M; Pietra, D; Casetti, Ic; Vanni, D; Trotti, C; Borghesi, A; Casanova, Jl; Arcaini, L; Rumi, E. | |
Mutation Type As a Major Determinant of Clinical Phenotype in Myeloproliferative Neoplasms Associated with Mutant Calreticulin | 1-gen-2014 | Pietra, Daniela; Rumi, Elisa; Chiara, Milanesi; DI BUDUO, CHRISTIAN ANDREA; Bellini, Marta; Casetti, ILARIA CAROLA; Cavalloni, Chiara; Sant'Antonio, Emanuela; Abbonante, Vittorio; Renna, MARIA CONCETTA; Ferretti, VIRGINIA VALERIA; Boveri, Emanuela; Balduini, Alessandra; Pascutto, Cristiana; Cazzola, Mario | |
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis | In corso di stampa | Mora, B.; Siracusa, C.; Rumi, E.; Maffioli, M.; Casetti, I. C.; Barraco, D.; Merli, M.; Rossi, M.; Ubezio, M.; Accetta, R.; Libera, L.; Pietra, D.; Trotti, C.; Uccella, S.; Pallotti, F.; Casalone, R.; Bertu, L.; Arcaini, L.; Della Porta, M. G.; Passamonti, F. | |
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients | 1-gen-2022 | Mora, B; Guglielmelli, P; Kuykendall, A; Rumi, E; Maffioli, M; Palandri, F; De Stefano, V; Caramella, M; Salmoiraghi, S; Kiladjian, Jj; Gotlib, J; Iurlo, A; Cervantes, F; Ruggeri, M; Silver, Rt; Albano, F; Benevolo, G; Ross, Dm; Della Porta, Mg; Devos, T; Rotunno, G; Komrokji, Rs; Casetti, Ic; Merli, M; Brociner, M; Caramazza, D; Auteri, G; Barbui, T; Cattaneo, D; Bertù, L; Arcaini, L; Vannucchi, Am; Passamonti, F. | |
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms | 1-gen-2023 | Borsani, O; Ferretti, Vv; Casetti, Ic; Vanni, D; Trotti, C; Pietra, D; De Silvestri, A; Arcaini, L; Rumi, E. | |
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms | 1-gen-2023 | Pecquet, C; Papadopoulos, N; Balligand, T; Chachoua, I; Tisserand, A; Vertenoeil, G; Nédélec, A; Vertommen, D; Roy, A; Marty, C; Nivarthi, H; Defour, Jp; El-Khoury, M; Hug, E; Majoros, A; Xu, E; Zagrijtschuk, O; Fertig, Te; Marta, Ds; Gisslinger, H; Gisslinger, B; Schalling, M; Casetti, I; Rumi, E; Pietra, D; Cavalloni, C; Arcaini, L; Cazzola, M; Komatsu, N; Kihara, Y; Sunami, Y; Edahiro, Y; Araki, M; Lesyk, R; Buxhofer-Ausch, V; Heibl, S; Pasquier, F; Havelange, V; Plo, I; Vainchenker, W; Kralovics, R; Constantinescu, Sn. | |
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms | 1-gen-2022 | Ibarra, J; Elbanna, Ya; Kurylowicz, K; Ciboddo, M; Greenbaum, Hs; Arellano, Ns; Rodriguez, D; Evers, M; Bock-Hughes, A; Liu, C; Smith, Q; Lutze, J; Baumeister, J; Kalmer, M; Olschok, K; Nicholson, B; Silva, D; Maxwell, L; Dowgielewicz, J; Rumi, E; Pietra, D; Casetti, Ic; Catricala, S; Koschmieder, S; Gurbuxani, S; Schneider, Rk; Oakes, Sa; Elf, Se. |